Taysha Gene Therapies Inc Cash Flow Reinvestment Rate
Taysha Gene Therapies Inc cash flow reinvestment rate. Taysha Gene Therapies Inc (TSHA) has a Cash Flow Reinvestment Rate of 0.33x as of December 2022, reinvesting $4.68 Million (capex $2.31 Million plus investments $-2.37 Million) from operating cash flow of $14.28 Million. Explore Taysha Gene Therapies Inc (TSHA) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Taysha Gene Therapies Inc (2019–2019)
Cash flow reinvestment rate of Taysha Gene Therapies Inc from 2019 to 2019. Historical reinvestment intensity for Taysha Gene Therapies Inc across 1 annual periods. Explore reinvestment intensity of Taysha Gene Therapies Inc to see what proportion of operating cash flow is directed to capital expenditures.
Taysha Gene Therapies Inc Cash Flow Reinvestment Rate by Year (2019–2019)
Taysha Gene Therapies Inc cash flow reinvestment rate by year from 2019 to 2019. Year-by-year capital reinvestment analysis for Taysha Gene Therapies Inc. For the full cash flow conversion analysis, see TSHA operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.61x | $82.00K | $135.00K | $82.00K | — |